OGS Executive Director Lois Schoenbrun announces retirement

News
Article

Schoenbrun will retire from the organization in December after coming out of retirement to serve as the interim executive director for OGS in 2022.

Lois Schoenbrun

Lois Schoenbrun / Image credit: Optometry Giving Sight

Optometry Giving Sight (OGS) recently announced Lois Schoenbrun, FAAO, the executive director of OGS, will retire from the organization in December 2024. The announcement comes after Schoenbrun came out of retirement in 2022 to serve as interim executive director for OGS, according to a news release.1

In a statement regarding her retirement, Schoenbrun said, “Although the initial interim period was intended to be short. I believed so passionately in the mission and quickly saw what a tremendous difference OGS makes in lives of people all over the world. So, the ‘interim’ appointment turned into nearly 2 and a half years. And I have enjoyed every minute of it.”

Schoenbrun’s colleagues also shared their remarks on working with her, including OGS US Board Chair Juan Carlos Aragón, OD. “When Lois joined OGS, we knew that we were getting a seasoned, successful leader from the optometry community. We are very appreciative of all that she and her team have accomplished, particularly in such a short period of time,” he said in the release.

Aragón also acknowledged Schonebrun’s achievements with OGS, including earning a 4-star designation from the non-profit assessment firm Charity Navigator. The designation is the highest rating possible for a non-profit and was a first for the organization.1

Susan Cooper, OD, chair of OGS’s Canada board, said in the release, “Under Lois’s leadership, we’ve strengthened the financial future of OGS, revised our vision and mission statement language to better align with the World Health Organization, and created additional staff positions to bring much-needed expertise in-house.”

A nationwide search to replace Schoenbrun is now taking place. Information regarding the open position can be found here.1

Reference:
  1. Lois Schoenbrun to retire as OGS executive director, nationwide search underway for successor. News release. Optometry Giving Sight. July 19, 2024. Accessed July 22, 2024. https://givingsight.org/news/lois-schoenbrun-to-retire-as-ogs-executive-director/
Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.